Skip to content
sellModerate cluster of 310b5-1 plan

Mark McKechnie sold $1.1M of ACMR

See Remarks at ACM Research, Inc.. 31,250 shares at an average of $34.93, traded Dec 4, 2025, filed Dec 8, 2025.

Warning score
40
Value
$1.1M
31,250 shares
Holdings after
900
-324% from before
From 52-week low
+146%
low $14.10, close $34.62
From 52-week high
-21%
high $43.78, as of Dec 4, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $1.1M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    3 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ACMROct 9, 2026 · close 71.37
Since filing Dec 8, 2025: +95.3%SPY +15.1% · excess +80.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001140361-25-044909, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 4, 2025MOption exercise
Class A Common Stock10b5-1
+8,750$4.55$40k9,650Dec 8, 2025
Dec 4, 2025SOpen-market sale
Class A Common Stock10b5-1
-7,754$33.50$260k1,896Dec 8, 2025
Dec 4, 2025SOpen-market sale
Class A Common Stock10b5-1
-996$34.26$34k900Dec 8, 2025
Dec 8, 2025MOption exercise
Class A Common Stock10b5-1
+22,500$25.45$573k23,400Dec 8, 2025
Dec 8, 2025SOpen-market sale
Class A Common Stock10b5-1
-22,500$35.45$798k900Dec 8, 2025
Dec 4, 2025MOption exercise
Stock Optionderivative10b5-1
-8,750$0.00$00Dec 8, 2025
Dec 8, 2025MOption exercise
Stock Optionderivative10b5-1
-22,500$0.00$00Dec 8, 2025

Related signals

Other insiders at ACM Research, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
10Weak
ACMRsell10b5-1
ACM Research, Inc.
David H Wang
See Remarks
$11M
140,000 shares
-16%
25Weak
ACMRsell 610b5-1
ACM Research, Inc.
David H Wang
See Remarks
$5.2M
110,000 shares
-13%
40Moderate
ACMRsell 610b5-1
ACM Research, Inc.
Mark McKechnie
See Remarks
$4.5M
98,551 shares
-162%
30Weak
ACMRsell 610b5-1
ACM Research, Inc.
Tracy Liu
director
$2.9M
60,000 shares
-39%
27Weak
ACMRsell 610b5-1
ACM Research, Inc.
Haiping Dun
director
$217k
5,000 shares
-100%
30Weak
ACMRsell 610b5-1
ACM Research, Inc.
Lisa Feng
See remarks
$1.4M
30,000 shares
-46%
28Weak
ACMRsell 610b5-1
ACM Research, Inc.
Charles C Pappis
director
$250k
5,000 shares
-100%
25Weak
ACMRsell 310b5-1
ACM Research, Inc.
David H Wang
See Remarks
$4.4M
130,000 shares
-15%
40Moderate
ACMRsell 310b5-1
ACM Research, Inc.
Fuping Chen
See remarks
$4.0M
120,000 shares
-120%
15Weak
ACMRsell10b5-1
ACM Research, Inc.
Lisa Feng
See remarks
$998k
30,000 shares
-46%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark McKechnie sold $1.1M of ACMR | InsiderTell